2025-02-01 - Analysis Report
## Newmont Corporation (NEM) Stock Review

**0. Key Figures Overview:**

Newmont Corporation (NEM) is a leading gold producer with significant operations worldwide.  The following analysis uses provided data to assess NEM's performance against the S&P 500 (VOO).

**1. Performance Comparison with S&P 500 (VOO):**

* **NEM Cumulative Return:** 34.33%
* **VOO Cumulative Return:** 119.91%
* **Return Difference:** -85.6% (NEM underperformed VOO significantly).
* **Relative Divergence:** 7.3% (indicates NEM's underperformance is in the lower percentile of historical performance relative to VOO's performance)


The provided alpha and beta analysis shows varying performance across different time periods. While some periods show positive alpha (outperformance relative to the market), more recent periods (2021-2025) show negative CAGR and significant negative alpha, indicating considerable underperformance against the market benchmark.  The beta fluctuates, implying varying sensitivity to market movements over time. Market capitalization (Cap(B)) generally increased over the time period, indicating a growing company.


**2. Recent Price Movement:**

* **Closing Price:** $42.72
* **5-Day Moving Average:** $42.06
* **20-Day Moving Average:** $40.65
* **60-Day Moving Average:** $40.98

The price is slightly above the 5-day and 20-day moving averages, suggesting some recent upward momentum, but below the 60-day moving average, which shows a longer-term trend of lower prices. The price dropped by $0.85 (-0.86%) from the previous close, indicating a minor decline.


**3. Technical Indicators and Expected Return:**

* **RSI:** 75.56 (indicates the stock is in overbought territory, suggesting potential for a price correction).
* **PPO:** 0.72 (positive value suggests a bullish trend).
* **20-Day Relative Divergence Change:** +2.2% (short-term upward trend).
* **Expected Return:** -233.5% (This extremely negative expected return relative to the S&P 500 needs clarification.  The calculation methodology should be provided to understand this significant underperformance prediction.  It's crucial to understand whether this refers to a short-term or long-term prediction and what assumptions are made).

The significant negative change in the price from the previous close (-$0.86) reflects a recent price decline, which is consistent with the generally negative performance in relation to the S&P 500.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2024-10-24 | $0.80 | $4.61 Billion |
| 2024-07-25 | $0.74 | $4.40 Billion |
| 2024-04-29 | $0.15 | $4.02 Billion |
| 2023-10-26 | $0.20 | $2.49 Billion |
| 2024-10-24 | $0.20 | $2.49 Billion |

There appears to be a duplicate entry for October 24, 2024.  Assuming this is an error, revenue and EPS show significant growth in the second and third quarters of 2024 compared to the previous year. However, there is a potential data error that requires clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---------|----------|---------------|
| 2024-09-30 | $4.61B  | 36.13%       |
| 2024-06-30 | $4.40B  | 37.35%       |
| 2024-03-31 | $4.02B  | 31.39%       |
| 2023-12-31 | $3.96B  | 24.59%       |
| 2023-09-30 | $2.49B  | 25.75%       |

Revenue shows a clear upward trend, with significant growth in the last two quarters of 2024. Profit margins are also healthy, though they fluctuated slightly.


**Capital and Profitability:**

| Quarter | Equity   | ROE     |
|---------|----------|---------|
| 2024-09-30 | $29.71B | 3.10%   |
| 2024-06-30 | $29.38B | 2.90%   |
| 2024-03-31 | $28.89B | 0.59%   |
| 2023-12-31 | $29.03B | -10.88%  |
| 2023-09-30 | $19.07B | 0.83%   |

Equity has generally increased, while ROE shows significant variability, experiencing a large negative value in the last quarter of 2023.


**6. Overall Analysis:**

NEM has shown strong revenue and profit growth in recent quarters, despite a recent price decline and considerable underperformance relative to the S&P 500. Technical indicators suggest the stock might be overbought. The extremely negative long-term expected return (-233.5%) requires further investigation to understand its basis.  The significant fluctuation in ROE raises concerns about the company's profitability.  Before making investment decisions, it's essential to address data inconsistencies, clarify the methodology behind the extremely negative expected return, and conduct thorough due diligence, considering the company's industry trends, future projections, and risk factors.  The data suggests a need for cautious optimism, focusing on fundamental analysis to better understand the sustainability of the positive revenue growth and the reasons for the large underperformance relative to the S&P 500.
